Funding for this research was provided by:
Novartis Pharma (This study was funded in part by an unrestricted scientific grant from Novartis to the UKE)
Received: 19 June 2019
Accepted: 23 July 2019
First Online: 1 August 2019
Ethics approval and consent to participate
: This study was approved by the local ethics committee of the chamber of physicians of Hamburg, Germany (PV 3185) and patients gave written informed consent according to the Declaration of Helsinki.
: None regarding the content of this paper.CZ received speaker honoraria and from Novartis, Teva, Allergan and Lilly and received consulting fees from Novartis and Teva.TPJ received honoraria and consulting fees from Autonomic Technologies, Inc., Allergan, Lilly, Novartis and TEVA. He also received travel grants from Allergan.GB and AM report no competing interests.